By HBM · Published 2026-09-11 · Updated 2026-09-11 · 2 min read

Bacopa Monnieri is an Ayurvedic herb used for memory and cognition, standardized to its active bacosides. The manufacturing job is twofold: sourcing an extract at a defined bacoside percentage, and managing a genuinely bitter, fat-associated active in a palatable format. HBM manufactures Bacopa into gummies and liquid shots in Tampa Bay, FL, formulating around the standardization the brand specifies and confirming it against the incoming COA.

Bacoside standardization

Bacopa’s actives are the bacosides, and extracts are sold at a defined percentage, commonly 20 to 55 percent bacosides. The percentage sets the effective dose and the cost, so it is the first thing to lock. HBM works to the standardization the customer specifies and verifies the bacoside content against the COA rather than assuming it from the label.

Dosing and taste

Bacopa is typically dosed around 300 mg of a standardized extract per serving. It is distinctly bitter, which is the main formulation challenge, so the flavor system and any masking are built around it. In a gummy the bitterness is balanced with the flavor and sweetness system; in a liquid shot it is managed within the wider blend.

Nootropic stacks and formats

Bacopa is usually part of a broader nootropic or adaptogen stack with Rhodiola, Ashwagandha, and Lion’s Mane, where each herb brings its own taste to manage. It fits gummies and liquid shots. HBM makes it at a gummy MOQ of 300,000 units and a liquid MOQ of 3,000 units or 150L, building the flavor around the full stack.

Ingredient at a glance

Common name	Bacopa Monnieri (Brahmi)
Plant part	Aerial parts
Key actives	Bacosides
Standardization	Commonly 20 to 55 percent bacosides
Typical dose	Around 300 mg standardized extract
Key constraint	Bitter taste; standardization
Best formats	Gummy, liquid shot

FAQ